CRISPR/Cas9 Technology–Based Xenograft Tumors as Candidate Reference Materials for Multiple EML4-ALK Rearrangements Testing  Rongxue Peng, Rui Zhang,

Slides:



Advertisements
Similar presentations
Molecular Therapy - Nucleic Acids
Advertisements

Targeted Disruption of V600E-Mutant BRAF Gene by CRISPR-Cpf1
Hepatitis C Virus RNA Real-Time Quantitative RT-PCR Method Based on a New Primer Design Strategy  Lida Chen, Wenli Li, Kuo Zhang, Rui Zhang, Tian Lu,
A Genome-Wide High-Resolution Array-CGH Analysis of Cutaneous Melanoma and Comparison of Array-CGH to FISH in Diagnostic Evaluation  Lu Wang, Mamta Rao,
Volume 204, Issue 1, Pages (January 2011)
Ane Y. Schmidt, Thomas v. O. Hansen, Lise B
Detection of TMPRSS2-ETS Fusions by a Multiprobe Fluorescence in Situ Hybridization Assay for the Early Diagnosis of Prostate Cancer  Qi-Peng Sun, Liao-Yuan.
Hepatitis C Virus RNA Real-Time Quantitative RT-PCR Method Based on a New Primer Design Strategy  Lida Chen, Wenli Li, Kuo Zhang, Rui Zhang, Tian Lu,
Droplet Digital PCR for Absolute Quantification of EML4-ALK Gene Rearrangement in Lung Adenocarcinoma  Qiushi Wang, Xin Yang, Yong He, Qiang Ma, Li Lin,
Carol Beadling, Tanaya L. Neff, Michael C
A Strategy to Find Suitable Reference Genes for miRNA Quantitative PCR Analysis and Its Application to Cervical Specimens  Iris Babion, Barbara C. Snoek,
Assessing Copy Number Alterations in Targeted, Amplicon-Based Next-Generation Sequencing Data  Catherine Grasso, Timothy Butler, Katherine Rhodes, Michael.
Detection of TMPRSS2-ETS Fusions by a Multiprobe Fluorescence in Situ Hybridization Assay for the Early Diagnosis of Prostate Cancer  Qi-Peng Sun, Liao-Yuan.
Comprehensive Screening of Gene Copy Number Aberrations in Formalin-Fixed, Paraffin-Embedded Solid Tumors Using Molecular Inversion Probe–Based Single-
RNAscope The Journal of Molecular Diagnostics
Hendrikus J. Dubbink, Peggy N. Atmodimedjo, Ronald van Marion, Niels M
A Single-Tube Multiplexed Assay for Detecting ALK, ROS1, and RET Fusions in Lung Cancer  Maruja E. Lira, Yoon-La Choi, Sun Min Lim, Shibing Deng, Donghui.
A Multiplex SNaPshot Assay as a Rapid Method for Detecting KRAS and BRAF Mutations in Advanced Colorectal Cancers  Sandrine Magnin, Erika Viel, Alice.
Isothermal Multiple Displacement Amplification
Tony L. Ng, Maureen J. O'Sullivan, Catherine J
Application of Single-Molecule Amplification and Resequencing Technology for Broad Surveillance of Plasma Mutations in Patients with Advanced Lung Adenocarcinoma 
Application of Single-Molecule Amplification and Resequencing Technology for Broad Surveillance of Plasma Mutations in Patients with Advanced Lung Adenocarcinoma 
Clinical Relevance of Sensitive and Quantitative STAT3 Mutation Analysis Using Next- Generation Sequencing in T-Cell Large Granular Lymphocytic Leukemia 
Molecular Diagnosis of Autosomal Dominant Polycystic Kidney Disease Using Next- Generation Sequencing  Adrian Y. Tan, Alber Michaeel, Genyan Liu, Olivier.
Christopher R. Cabanski, Vincent Magrini, Malachi Griffith, Obi L
A Comprehensive Strategy for Accurate Mutation Detection of the Highly Homologous PMS2  Jianli Li, Hongzheng Dai, Yanming Feng, Jia Tang, Stella Chen,
Molecular Diagnosis in Ewing Family Tumors
Undifferentiated Small Round Cell Sarcomas with Rare EWS Gene Fusions
Molecular Analysis of Gene Fusions in Bone and Soft Tissue Tumors by Anchored Multiplex PCR–Based Targeted Next-Generation Sequencing  Suk Wai Lam, Anne-Marie.
ALK Status Testing in Non–Small Cell Lung Carcinoma
Molecular Therapy - Nucleic Acids
Getting Things Backwards to Prevent Primer Dimers
Multiplexed Gene Expression and Fusion Transcript Analysis to Detect ALK Fusions in Lung Cancer  Maruja E. Lira, Tae Min Kim, Donghui Huang, Shibing Deng,
Rapid Detection of Haptoglobin Gene Deletion in Alkaline-Denatured Blood by Loop- Mediated Isothermal Amplification Reaction  Mikiko Soejima, Kouichi Egashira,
A Genome-Wide High-Resolution Array-CGH Analysis of Cutaneous Melanoma and Comparison of Array-CGH to FISH in Diagnostic Evaluation  Lu Wang, Mamta Rao,
A Multiplex qPCR Gene Dosage Assay for Rapid Genotyping and Large-Scale Population Screening for Deletional α-Thalassemia  Wanjun Zhou, Ge Wang, Xuefeng.
Volume 154, Issue 6, Pages (September 2013)
Cyclin E1 Is Amplified and Overexpressed in Osteosarcoma
Benjamin P. Song, Surbhi Jain, Selena Y. Lin, Quan Chen, Timothy M
Diagnostic Utility of Molecular Investigation in Extraskeletal Myxoid Chondrosarcoma  Stefania Benini, Stefania Cocchi, Gabriella Gamberi, Giovanna Magagnoli,
Combinational Analysis of FISH and Immunohistochemistry Reveals Rare Genomic Events in ALK Fusion Patterns in NSCLC that Responds to Crizotinib Treatment 
The MECT1-MAML2 Gene Fusion and Benign Warthin's Tumor
A Multi-Site Study for Detection of the Factor V (Leiden) Mutation from Genomic DNA Using a Homogeneous Invader Microtiter Plate Fluorescence Resonance.
Reliability Assurance of Detection of EML4-ALK Rearrangement in Non–Small Cell Lung Cancer: The Results of Proficiency Testing in China  Yulong Li, MD,
Technical Validation of a Next-Generation Sequencing Assay for Detecting Clinically Relevant Levels of Breast Cancer–Related Single-Nucleotide Variants.
RNA-Guided Genome Editing in Plants Using a CRISPR–Cas System
Sanger Confirmation Is Required to Achieve Optimal Sensitivity and Specificity in Next- Generation Sequencing Panel Testing  Wenbo Mu, Hsiao-Mei Lu, Jefferey.
A Novel Approach to Detect Programed Death Ligand 1 (PD-L1) Status and Multiple Tumor Mutations Using a Single Non–Small-Cell Lung Cancer (NSCLC) Bronchoscopy.
External Quality Assessment for Detection of Fetal Trisomy 21, 18, and 13 by Massively Parallel Sequencing in Clinical Laboratories  Rui Zhang, Hongyun.
Detection of ALK Rearrangement by Immunohistochemistry in Lung Adenocarcinoma and the Identification of a Novel EML4-ALK Variant  Ka-Fai To, MBChB, Joanna.
A Novel Method for Creating Artificial Mutant Samples for Performance Evaluation and Quality Control in Clinical Molecular Genetics  Michael Jarvis, Ramaswamy.
Genomic Technologies and the New Era of Genomic Medicine
Volume 9, Issue 4, Pages (November 2014)
Low Incidence of Minor BRAF V600 Mutation-Positive Subclones in Primary and Metastatic Melanoma Determined by Sensitive and Quantitative Real-Time PCR 
Ming-Tseh Lin, Li-Hui Tseng, Roy G. Rich, Michael J
ChildSeq-RNA The Journal of Molecular Diagnostics
Danielle C. Smith, Alina Esterhuizen, Jacquie Greenberg 
A Pyrosequencing-Based Assay for the Rapid Detection of the 22q11
A Platform for Rapid Detection of Multiple Oncogenic Mutations With Relevance to Targeted Therapy in Non–Small-Cell Lung Cancer  Zengliu Su, Dora Dias-Santagata,
Volume 25, Issue 2, Pages (February 2017)
Molecular Therapy - Nucleic Acids
HIP1–ALK, A Novel ALK Fusion Variant that Responds to Crizotinib
Targeted Deletion of an Entire Chromosome Using CRISPR/Cas9
Volume 26, Issue 6, Pages (June 2018)
Ciaran M Lee, Thomas J Cradick, Gang Bao  Molecular Therapy 
A Second Leaky Splice-Site Mutation in the Spastin Gene
Jiamiao Lu, Feijie Zhang, Mark A Kay  Molecular Therapy 
Off-target Effects in CRISPR/Cas9-mediated Genome Engineering
Development of a Novel Next-Generation Sequencing Assay for Carrier Screening in Old Order Amish and Mennonite Populations of Pennsylvania  Erin L. Crowgey,
Preanalytic Variables and Tissue Stewardship for Reliable Next-Generation Sequencing (NGS) Clinical Analysis  Paolo A. Ascierto, Carlo Bifulco, Giuseppe.
Presentation transcript:

CRISPR/Cas9 Technology–Based Xenograft Tumors as Candidate Reference Materials for Multiple EML4-ALK Rearrangements Testing  Rongxue Peng, Rui Zhang, Guigao Lin, Xin Yang, Ziyang Li, Kuo Zhang, Jiawei Zhang, Jinming Li  The Journal of Molecular Diagnostics  Volume 19, Issue 5, Pages 766-775 (September 2017) DOI: 10.1016/j.jmoldx.2017.06.003 Copyright © 2017 American Society for Investigative Pathology and the Association for Molecular Pathology Terms and Conditions

Figure 1 Generation of EML4-ALK rearrangements by CRISPR/Cas9 system. A: Schematic of the strategy for generating EML4-ALK rearrangements. B–D: Detection of EML4-ALK fusions and fusion transcripts by PCR and RT-PCR on total DNA/RNA extracted from HEK293T cells transfected with corresponding vectors. E: Sequences of the RT-PCR products showing the correct EML4-ALK fusions. F: Western blotting for EML4-ALK protein expression in single clones. H3122 and H2228 were selected as positive controls, whereas HEK293T was selected as a negative control. The sequence of EML4 sgRNA is marked in yellow, and the sequence of ALK sgRNA is marked in green. Chr, chromosome. The Journal of Molecular Diagnostics 2017 19, 766-775DOI: (10.1016/j.jmoldx.2017.06.003) Copyright © 2017 American Society for Investigative Pathology and the Association for Molecular Pathology Terms and Conditions

Figure 2 Hematoxylin and eosin (H&E)–morphology, ALK-FISH, and ALK-IHC of 1-F8-G9, 9-E11-G5, 14-F9-E8, clinical specimens, and wild-type control. 1-F8-G9, 9-E11-G5, and 14-F9-E8 FFPE samples all display a high amount of tumor cells (A–C), detectable ALK breaks (F–H), and unequivocal ALK protein expression (K–M). The results are concordant with the native ALK-positive NSCLC tumors (D, I, and N). The wild-type control (HEK293T cells) displays negative results (E, J, and O). Red arrows indicate typical tumor cells stained by H&E, representative fluorescence signal of ALK breaks, and positive staining of IHC. Scale bars: 100 μm (A–E); 10 μm (F–J); 50 μm (K–O). Original magnification: ×200 (A–E); ×1000 (F–J); ×400 (K–O). The Journal of Molecular Diagnostics 2017 19, 766-775DOI: (10.1016/j.jmoldx.2017.06.003) Copyright © 2017 American Society for Investigative Pathology and the Association for Molecular Pathology Terms and Conditions

Figure 3 Sample validation and homogeneity and stability assessment of the novel FFPE reference materials by RT-qPCR. A: Sample validation by RT-qPCR of the novel FFPE reference materials. Data shown in the form of Cq ratio (EML4-ALK Cq/GAPDH Cq). B: Homogeneity and stability assessment of the novel FFPE reference materials showing that no significant trends in the Cq ratio are detectable within the detection limits of the assays. The mean values of all samples are consistent with their individual target values. The Journal of Molecular Diagnostics 2017 19, 766-775DOI: (10.1016/j.jmoldx.2017.06.003) Copyright © 2017 American Society for Investigative Pathology and the Association for Molecular Pathology Terms and Conditions

Figure 4 Integrative Genomics Viewer (IGV) screenshots of the breakpoints in the EML4 and ALK genes detected by capture-based NGS. A: Fusion of EML4-ALK by capture-based DNA sequencing. The green line signifies the EML4-ALK variant 1, the orange line signifies the EML4-ALK variant 2, and the purple line signifies the EML4-ALK variant 3. B: The IGV screenshot of EML4-ALK rearrangement variant 1. C: The IGV screenshot of EML4-ALK rearrangement variant 2. D: The IGV screenshot of EML4-ALK rearrangement variant 3. Chr, chromosome. The Journal of Molecular Diagnostics 2017 19, 766-775DOI: (10.1016/j.jmoldx.2017.06.003) Copyright © 2017 American Society for Investigative Pathology and the Association for Molecular Pathology Terms and Conditions

Supplemental Figure S1 T7EI assay for each targeted genomic region. T7EI assay for EML4 sgRNA 1 and ALK sgRNA (A), EML4 sgRNA 2 and ALK sgRNA (B), and EML4 sgRNA 3 and ALK sgRNA (C). HEK293T cells were transfected with either the px330 vector expressing Cas9 endonuclease and specific sgRNAs or the px330 vector alone. For each sgRNA target site, the surrounding genomic region was amplified by PCR and subjected to the T7EI assay to evaluate the formation of insertions/deletions. The exons of the EML4 gene are marked in yellow, and exons of the ALK gene are marked in green. The cleavage sites are labeled as scissor symbols. The Journal of Molecular Diagnostics 2017 19, 766-775DOI: (10.1016/j.jmoldx.2017.06.003) Copyright © 2017 American Society for Investigative Pathology and the Association for Molecular Pathology Terms and Conditions

Supplemental Figure S2 Construction of s.c. xenograft mouse models. The s.c. xenograft model was prepared by injecting edited cells (1-F8-G9, 9-E11-G5, and 14-F9-E8) into the flanks of nude mice. At 4 weeks after injection, the average volumes of xenografted tumors were approximately 1000 mm3. The Journal of Molecular Diagnostics 2017 19, 766-775DOI: (10.1016/j.jmoldx.2017.06.003) Copyright © 2017 American Society for Investigative Pathology and the Association for Molecular Pathology Terms and Conditions